Advisor Group Holdings, Inc. Genmab A/S Transaction History

Advisor Group Holdings, Inc.

$52.6 Billion
Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Genmab A/S stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,603 shares of GMAB stock, worth $46,102. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,603

Previous 1,167 37.36%

Holding current value

$46,102

Previous $24,000 37.5%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Sep 04, 2025	BUY	$17.98 - $23.09 $7,839 - $10,067	436 Added 37.36%	1,603 $33,000
Q2 2025 Aug 13, 2025	BUY	$17.98 - $23.09 $71 - $92	4 Added 0.34%	1,167 $24,000
Q1 2025 May 12, 2025	SELL	$18.69 - $24.14 $24,184 - $31,237	-1,294 Reduced 52.67%	1,163 $22,000
Q4 2024 Jun 06, 2025	BUY	$20.02 - $24.15 $25,785 - $31,105	1,288 Added 110.75%	2,451 $51,000
Q4 2024 Feb 07, 2025	SELL	$20.02 - $24.15 $109,869 - $132,535	-5,488 Reduced 69.07%	2,457 $51,000
Q3 2024 Nov 13, 2024	BUY	$23.84 - $28.48 $17,069 - $20,391	716 Added 9.9%	7,945 $193,000
Q2 2024 Aug 13, 2024	SELL	$25.13 - $30.27 $582,337 - $701,446	-23,173 Reduced 76.22%	7,229 $181,000
Q1 2024 May 10, 2024	BUY	$26.43 - $32.77 $52,542 - $65,146	1,988 Added 7.0%	30,402 $909,000
Q4 2023 Feb 12, 2024	SELL	$27.94 - $35.44 $568,020 - $720,495	-20,330 Reduced 41.71%	28,414 $904,000
Q3 2023 Nov 13, 2023	BUY	$35.27 - $42.24 $783,452 - $938,277	22,213 Added 83.72%	48,744 $1.72 Million
Q2 2023 Aug 21, 2023	SELL	$37.4 - $42.94 $56,735 - $65,139	-1,517 Reduced 5.41%	26,531 $1.01 Million
Q2 2023 Aug 10, 2023	BUY	$37.4 - $42.94 $30,630 - $35,167	819 Added 3.01%	28,048 $1.07 Million
Q1 2023 May 12, 2023	SELL	$34.88 - $43.22 $171,121 - $212,037	-4,906 Reduced 15.27%	27,229 $1.03 Million
Q4 2022 Feb 10, 2023	BUY	$33.8 - $47.06 $287,671 - $400,527	8,511 Added 36.03%	32,135 $1.36 Million
Q3 2022 Nov 14, 2022	BUY	$31.52 - $373.61 $192,461 - $2.28 Million	6,106 Added 34.86%	23,624 $759,000
Q2 2022 Aug 10, 2022	BUY	$26.83 - $38.57 $80,999 - $116,442	3,019 Added 20.82%	17,518 $569,000
Q1 2022 May 04, 2022	SELL	$30.95 - $39.68 $105,106 - $134,753	-3,396 Reduced 18.98%	14,499 $1.38 Million
Q3 2021 Nov 05, 2021	BUY	$41.55 - $48.72 $151,906 - $178,120	3,656 Added 25.68%	17,895 $782,000
Q2 2021 Aug 02, 2021	SELL	$32.88 - $44.57 $375,325 - $508,766	-11,415 Reduced 44.5%	14,239 $583,000
Q1 2021 May 13, 2021	SELL	$30.92 - $44.4 $143,128 - $205,527	-4,629 Reduced 15.29%	25,654 $842,000
Q4 2020 Feb 10, 2021	BUY	$33.66 - $40.76 $134,673 - $163,080	4,001 Added 15.22%	30,283 $1.23 Million
Q3 2020 Nov 12, 2020	BUY	$33.07 - $38.68 $281,061 - $328,741	8,499 Added 47.79%	26,282 $960,000
Q2 2020 Aug 14, 2020	BUY	$20.05 - $33.89 $115,929 - $195,951	5,782 Added 48.18%	17,783 $603,000
Q1 2020 May 18, 2020	BUY	$17.15 - $25.22 $205,817 - $302,665	12,001 New	12,001 $254,000

Others Institutions Holding GMAB

# of Institutions

255

Shares Held

65.7M

Call Options Held

32.5K

Put Options Held

55K

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $18.9B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Genmab A/S Transaction History